Cargando...
Characterization of Estrogen-Receptor-Targeted Contrast-Agents in Solution, Breast Cancer Cells and Tumors in vivo
The estrogen receptor (ER) is a major prognostic biomarker of breast cancer, currently determined in surgical specimens by immunohistochemistry. Two new ER targeted probes, pyridine-tetra-acetate-Gd chelate (PTA-Gd) conjugated either to 17β-estradiol (EPTA-Gd) or to tamoxifen (TPTA-Gd), were explore...
Gardado en:
| Publicado en: | Magn Reson Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4547469/ https://ncbi.nlm.nih.gov/pubmed/22887470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mrm.24442 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|